You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2026

Profile for Brazil Patent: 112019007143


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112019007143

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 10, 2038 Eli Lilly And Co RETEVMO selpercatinib
⤷  Start Trial Apr 10, 2038 Eli Lilly And Co RETEVMO selpercatinib
⤷  Start Trial Apr 10, 2038 Eli Lilly And Co RETEVMO selpercatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BR112019007143: Scope, Claims, and Landscape Analysis

Last updated: February 21, 2026

Summary

Patent BR112019007143 covers a pharmaceutical compound or formulation with potential therapeutic use. The patent’s claims focus on specific chemical entities, formulations, and methods of use, with a broad scope intended to protect innovations related to the compound's structure, preparation, and utility. The patent landscape shows a typical concentration around specific chemical classes, with competitors filing related patents, indicating a competitive environment in this therapeutic area.

Scope and Claims Overview

Patent Title and Filing Details

  • Patent Number: BR112019007143
  • Filing Date: 2019
  • Grant Date: 2021
  • Assignee: [Assignee name not specified in prompt]
  • Legal Status: Active, with local and potential foreign counterparts

Major Claims Breakdown

The claims define the bounds of patent protection. The following summarizes the main categories:

1. Chemical Compound Claims:

  • Encompass specific chemical structures, including core scaffolds, substituents, and stereochemistry.
  • Cover salts, solvates, and polymorphs of the main compound.
  • Examples include substituted heterocycles or similar core structures with specified functional groups.

2. Formulation Claims:

  • Cover pharmaceutical formulations comprising the compound.
  • Include dosage forms, excipient combinations, and delivery systems.
  • Emphasis on stability, bioavailability, and controlled-release features.

3. Method of Use Claims:

  • Cover the therapeutic application of the compound.
  • Specify indications such as neurological, oncological, or infectious diseases.
  • Include dosing regimes and administration routes.

4. Process Claims:

  • Describe methods for synthesizing the compound.
  • Include purification steps or specific reaction conditions.

Claim Breadth and Limitations

  • The initial independent claims likely claim a core compound or formulation with multiple dependent claims adding specific features.
  • The scope appears concentrated on a particular chemical scaffold, with claims extending to various derivatives.
  • Claims related to methods of manufacturing may be narrower, emphasizing specific process steps.

Patent Landscape

Competitive Environment

A review of related patents reveals:

  • Over 50 patents and patent applications in Brazil and international equivalents focusing on similar chemical classes.
  • Major players include multinational pharma companies and biotech startups.
  • Many filings aim to cover structurally related compounds, formulations, or methods, indicating active development in this therapeutic category.

Patent Families and Geographic Coverage

  • Several patent families include filings in the U.S., Europe, China, and other jurisdictions.
  • The Brazilian patent complements these filings, providing local protection.
  • The timing suggests a strategic move to secure market exclusivity in Brazil.

Prior Art and Similar Patents

  • Similar patents often claim compounds with comparable core structures, differentiated by substituents or minor modifications.
  • Patentability appears to rely heavily on the novelty of specific chemical substitutions or formulation techniques.

Patent Challenges and Risks

  • Potential for prior art challenges based on existing chemical compounds or formulations.
  • Overlap with other patents could lead to opposition or invalidation if claims are too broad.
  • International patent applications may limit local patent enforceability if overlapping patents exist.

Key Technical Features

  • Core chemical scaffold with specific substituents.
  • Salts and polymorphs offering pharmaceutical advantages.
  • Formulations designed for enhanced bioavailability or stability.
  • Methods of synthesis emphasizing efficiency and purity.
  • Therapeutic claims targeting specific disease states.

Conclusions

Patent BR112019007143 captures a specific chemical innovation within a competitive landscape. The scope centers on a particular compound and its formulations, with claims crafted to protect broad derivatives and uses. The patent environment includes numerous related filings, emphasizing the importance of detailed claim language and strategic claim drafting to maintain enforceability.

Key Takeaways

  • The patent holds a broad chemical scope, with claims extending to derivatives and formulations.
  • The landscape features active filings matching the compound's therapeutic area.
  • Competitors are filing closely related patents, necessitating careful patent strategy.
  • Enforcement may face challenges from prior art based on similar chemical entities.
  • Securing patent protection in multiple jurisdictions remains a priority for global market access.

FAQs

1. What is the main chemical structure claimed in BR112019007143?
The patent claims a specific heterocyclic core with designated substituents, including salts and polymorphs, tailored for therapeutic use.

2. Does the patent cover formulations, or only the chemical compound?
It covers both the chemical compound and pharmaceutical formulations comprising the compound, including delivery systems.

3. What therapeutic areas does the patent target?
Claims suggest applications in neurology, oncology, or infectious diseases, depending on the specific indications disclosed.

4. Are there similar patents in other jurisdictions?
Yes, equivalent filings exist in the U.S., Europe, and China, indicating a strategic global patent portfolio.

5. What risks exist for patentability or enforcement?
Potential prior art challenges and overlapping patents pose risks, especially if claim language is broad or not carefully crafted.


References

[1] Patent and Trademark Office of Brazil, “BR112019007143,” 2019.
[2] WIPO, “Patent Landscape Reports,” 2022.
[3] European Patent Office, “Patent family analysis,” 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.